Structures by: Tsou N.
Total: 7
C27H23Cl3N4O2
C27H23Cl3N4O2
Journal of medicinal chemistry (2010) 53, 10 4028-4037
a=11.1695(8)Å b=11.2252(8)Å c=20.0044(14)Å
α=90.° β=90.° γ=90.°
(S)-ethyl (1-((4-((4-fluorobenzyl)carbamoyl)-1-methyl-2-(2-(5-methyl-1,3,4- oxadiazole-2-carboxamido)propan-2-yl)-6-oxo-1,6-dihydropyrimidin-5-yl) oxy)ethyl)
C25H29FN6O8
Organic Process Research & Development (2015) 19, 12 1882
a=9.4933(18)Å b=11.2461(19)Å c=24.486(4)Å
α=90.00° β=90.00° γ=90.00°
Ethyl (1-((4-((4-fluorobenzyl)carbamoyl)-1-methyl-2-(2-(5-methyl-1,3,4-oxadiazole-2-carboxamido) propan-2-yl)-6-oxo-1,6-dihydropyrimidin-5-yl)oxy)ethyl)
C25H29FN6O8
Organic Process Research & Development (2015) 19, 12 1882
a=11.2744(3)Å b=9.4324(3)Å c=25.6466(7)Å
α=90.00° β=102.205(2)° γ=90.00°
(Z)-N-(2-(4-((4-fluorobenzyl)imino)-2,7-dimethyl-8-oxo-7,8-dihydro-4H-[1,3 dioxino[5,4-d]pyrimidin-6-yl)propan-2-yl)-5-methyl-1,3,4-oxadiazole-2-carboxamide
C22H23FN6O5
Organic Process Research & Development (2015) 19, 12 1882
a=13.8135(4)Å b=13.3386(4)Å c=14.0876(4)Å
α=90° β=114.4961(11)° γ=90°
C17H18N2O5
C17H18N2O5
Journal of Organic Chemistry (2004) 69, 1298-1308
a=9.152(2)Å b=10.857(1)Å c=16.9778(9)Å
α=90° β=104.200(8)° γ=90°
Parc0107b
C30H22ClNO9
Journal of the American Chemical Society (2008) 130, 7060-7066
a=7.6433(7)Å b=11.0235(10)Å c=29.784(3)Å
α=90.00° β=90.00° γ=90.00°
Parc0105a
C24H19NO9
Journal of the American Chemical Society (2008) 130, 7060-7066
a=5.9784(9)Å b=22.907(3)Å c=14.639(2)Å
α=90.00° β=97.816(2)° γ=90.00°